Rupa Banerjee, Vishal Sharma, Rajendra Patel, Anuraag Jena, Partha Pal, Nalini Raghunathan, Ajay Kumar, Ajit Sood, Amarender S Puri, Bhabhadev Goswami, Devendra Desai, Dhanush Mekala, G N Ramesh, G V Rao, Kiran Peddi, Mathew Philip, Manu Tandon, Shobna Bhatia, Shubhankar Godbole, Sumit Bhatia, Uday C Ghoshal, Usha Dutta, Vandana Midha, V G Mohan Prasad, D Nageshwar Reddy
Rising number of inflammatory bowel disease (IBD) cases in developing countries necessitate clear guidance for clinicians for the appropriate use of advanced therapies. An expert consensus document was generated to guide the usage of tofacitinib, a Janus kinase inhibitor, in ulcerative colitis. Tofacitinib is a useful agent for the induction and maintenance of remission in ulcerative colitis. It can be used in the setting of biological failure or even steroid-dependent and thiopurine refractory disease...
February 12, 2024: Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology